Trexquant Investment LP Blueprint Medicines Corp Transaction History

Trexquant Investment LP

  • $8.06 Billion
  • Q4 2024

A detailed history of Trexquant Investment LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Trexquant Investment LP holds 127,098 shares of BPMC stock, worth $11.6 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
127,098
Previous 118,545 7.21%
Holding current value
$11.6 Million
Previous $11 Million 1.14%
% of portfolio
0.14%
Previous 0.14%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$82.48 - $101.39 $705,451 - $867,188
8,553 Added 7.21%
127,098 $11.1 Million
Q3 2024

Nov 12, 2024
SELL
$84.1 - $120.5 $1.24 Million - $1.77 Million
-14,698 Reduced 11.03%
118,545 $11 Million
Q2 2024

Aug 13, 2024
BUY
$85.18 - $108.78 $11.2 Million - $14.2 Million
130,946 Added 5700.74%
133,243 $14.4 Million
Q1 2024

May 14, 2024
SELL
$73.17 - $99.79 $4 Million - $5.45 Million
-54,635 Reduced 95.97%
2,297 $217,000
Q4 2023

Feb 09, 2024
BUY
$43.96 - $92.84 $2.5 Million - $5.29 Million
56,932 New
56,932 $5.25 Million
Q3 2022

Nov 14, 2022
BUY
$49.93 - $77.7 $4.32 Million - $6.72 Million
86,523 Added 1602.57%
91,922 $6.06 Million
Q2 2022

Aug 11, 2022
BUY
$45.23 - $70.15 $244,196 - $378,739
5,399 New
5,399 $273,000
Q4 2020

Feb 11, 2021
SELL
$92.08 - $124.48 $378,356 - $511,488
-4,109 Closed
0 $0
Q3 2020

Nov 06, 2020
SELL
$66.45 - $92.7 $580,042 - $809,178
-8,729 Reduced 67.99%
4,109 $381,000
Q2 2020

Aug 07, 2020
SELL
$57.09 - $79.27 $1.23 Million - $1.71 Million
-21,585 Reduced 62.71%
12,838 $1 Million
Q1 2020

May 08, 2020
BUY
$48.11 - $82.22 $1.52 Million - $2.59 Million
31,513 Added 1082.92%
34,423 $2.01 Million
Q4 2019

Feb 12, 2020
BUY
$66.73 - $82.59 $194,184 - $240,336
2,910 New
2,910 $233,000
Q3 2019

Nov 08, 2019
SELL
$72.9 - $101.41 $157,172 - $218,639
-2,156 Closed
0 $0
Q2 2019

Aug 09, 2019
BUY
$73.54 - $97.8 $158,552 - $210,856
2,156 New
2,156 $203,000
Q1 2019

May 13, 2019
SELL
$48.7 - $86.6 $1.35 Million - $2.41 Million
-27,774 Closed
0 $0
Q4 2018

Feb 13, 2019
BUY
$45.57 - $74.26 $304,453 - $496,131
6,681 Added 31.67%
27,774 $1.5 Million
Q3 2018

Nov 09, 2018
BUY
$58.91 - $78.32 $1.24 Million - $1.65 Million
21,093 New
21,093 $1.65 Million
Q2 2018

Aug 07, 2018
SELL
$60.96 - $101.18 $1.18 Million - $1.95 Million
-19,279 Closed
0 $0
Q1 2018

May 03, 2018
BUY
$73.28 - $102.95 $1.41 Million - $1.98 Million
19,279 New
19,279 $1.77 Million

Others Institutions Holding BPMC

# of Institutions
380
Shares Held
65.9M
Call Options Held
1.6M
Put Options Held
1.41M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.46B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email